Rep. Brad Wenstrup @RepBradWenstrup
"The Gaithersburg, Md., company said the pivotal Phase 3 trial in the U.K. would track whether adults receiving its two-dose vaccine experience a lower rate of symptomatic Covid-19 compared with study subjects who get a placebo." #OperationWarpSpeed https://t.co/JInEn7CRGa — PolitiTweet.org